Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 850.00 KRW
Change Today +82.00 / 10.68%
Volume 27.6M
002630 On Other Exchanges
Korea SE
As of 2:27 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

orientbio inc (002630) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/20/14 - 1,038
52 Week Low
06/30/14 - 441.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ORIENTBIO INC (002630)

Related News

No related news articles were found.

orientbio inc (002630) Related Businessweek News

No Related Businessweek News Found

orientbio inc (002630) Details

Orientbio, Inc. operates in the biotechnology business and provides new drug discovery support. It produces various research models, including rabbits and mice to laboratories; and provides contract research organization (CRO) services, including preclinical, clinical, and biopharmaceutical services. The company also offers medical and lab equipment for universities, hospitals, and research centers; specific pathogen free (SPF) eggs and avian specialties; feed, including certified, standard, and irradiated diets; bedding for research animals; reagents; equipments and systems in Industrial Clean Room, as well as maintenance services; and disinfectants. Orientbio, Inc. was founded in 1959 and is based in Seongnam-si, South Korea.

Founded in 1959

orientbio inc (002630) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

orientbio inc (002630) Key Developments

Orientbio, Inc., Special/Extraordinary Shareholders Meeting, Dec 19, 2014

Orientbio, Inc., Special/Extraordinary Shareholders Meeting, Dec 19, 2014., at 09:00 Korea Standard Time. Location: 322 to go though Jungwon-gu Seongnam, Ltd. Agenda: To consider the audit senior articles.

Orientbio, Inc., Annual General Meeting, Jun 27, 2014

Orientbio, Inc., Annual General Meeting, Jun 27, 2014., at 09:00 Korea Standard Time. Location: 322 Jungwon Co., Orient Bio Headquarters second floor multi-purpose Hall. Agenda: To consider the sales report and audit report; to consider financial statement (statement of financial position, income statement and statement of (not)); to consider some changes of bylaws; to consider election of outside directors; to consider directors remuneration; and to consider the remuneration of the audit.

Orientbio, Inc. - Shareholder/Analyst Call

Orientbio, Inc. - Shareholder/Analyst Call


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002630:KS 850.00 KRW +82.00

002630 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002630.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002630 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORIENTBIO INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at